Company Filing History:
Years Active: 2020-2022
Title: Lucille Lamouroux: Innovator in Viral Particle Technology
Introduction
Lucille Lamouroux is a prominent inventor based in Pinsaguel, France. She has made significant contributions to the field of viral particle technology, focusing on innovative methods for RNA transfer and genome engineering. With a total of 2 patents, her work is paving the way for advancements in immunology and genetic research.
Latest Patents
Lamouroux's latest patents include groundbreaking inventions that enhance the transfer of RNAs into immune response cells. The first patent, titled "Viral particle for the transfer of RNAs, especially into cells involved in immune response," describes a retroviral particle that comprises a protein derived from the Gag polyprotein, an envelope protein, and encapsidated non-viral RNAs. These RNAs are designed to carry RNA sequences of interest, which can include coding for specific epitopes or molecular structures that recognize epitopes.
The second patent, "Particle for the encapsidation of a genome engineering system," also involves a retroviral particle with similar components. This invention focuses on encapsidated non-viral RNAs that include a part coding for a nuclease, further expanding the potential applications of her research in genome engineering.
Career Highlights
Lucille Lamouroux is currently associated with Flash Therapeutics, where she continues to innovate in the field of viral particle technology. Her work is characterized by a commitment to advancing scientific understanding and practical applications in immunology and genetic engineering.
Collaborations
One of her notable collaborators is Pascale Bouille, who contributes to the research and development efforts at Flash Therapeutics. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Lucille Lamouroux's contributions to viral particle technology and RNA transfer are significant in the fields of immunology and genetic engineering. Her patents reflect a deep understanding of the complexities of viral particles and their applications in modern science. Through her work, she is making a lasting impact on the future of medical research and treatment.